Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma: a randomised, open-label, phase 2 trial. - Chong WQ; Low JL; Tay JK; Le TBU; Goh GS; Sooi K; Teo HL; Cheo SW; Wong RT; Samol J; Lim MY; Li H; et al. (The Lancet. Oncology, 2025)